A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Intravitreal OLN324

Clinical trial NCT07484074 · COMPLETED

Trial details

NCT number: NCT07484074
Sponsor: Ollin Biosciences, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetic Macular Edema (DME)Neovascular (Wet) Age-Related Macular Degeneration

Start date: 2025-02-12
Primary completion: 2025-10-10
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.